Rapid risk assessment: A(H5N1) Highly Pathogenic Avian Influenza in Egypt – Implications for human health in Europe
Highly pathogenic avian influenza A(H5N1) infections are continuing to occur in poultry and humans in Egypt. However there is no evidence of a significant change in the pattern of human illness and deaths related to A(H5N1) virus infections in the country. Certainly there are no epidemiological data or analyses consistent with adaptation of these viruses to humans.
Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.
Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). Eleventh update, 21 August 2014
This eleventh updated rapid risk assessment on MERS-CoV shows that the number of cases has been steadily declining in the last few months.
Rapid risk assessment: human infection with avian influenza A(H5N1) virus, Egypt, 23 December 2014
According to a WHO update published on 4 December 2014, eight new human cases of influenza A(H5N1) have been reported in Egypt, with onset of disease in November 2014, bringing the total for 2014 to 12.
Rapid risk assessment: Human infection with avian influenza A(H5N1) virus, Egypt - 1st update, 13 March 2015
Human cases and fatalities due to influenza A(H5N1) virus continue to increase in Egypt, with cases from the country now accounting for the highest number of human cases reported worldwide.
Severe respiratory disease associated with Middle East respiratory syndrome coronavirus - 21st update, 21 October 2015
This 21st update of ECDC’s risk assessment on MERS-CoV has been triggered by an increase in MERS cases acquired through nosocomial transmission in Amman, Jordan.